Micro Medical Solutions announced today that it completed enrollment in a U.S. pivotal clinical study of its MicroStent system. Wilmington, Massachusetts-based Micro Medical set up its study to evaluate MicroStent’s safety and effectiveness. The study pits the stent against the current standard of care, percutaneous transluminal angioplasty (PTA). MicroStent, a vascular stent, was designed to […]
Micro Medical Solutions
Micro Medical Solutions wins FDA breakthrough device designation for vascular stent
Micro Medical Solutions today said it has received FDA breakthrough device designation for its MicroStent vascular stent. The stent is designed to maintain vessel patency, enhance wound treatment and improve quality of life and blood flow to reduce amputations and mortality for patients with critical limb-threatening ischemia (CLTI) from peripheral artery disease. “FDA breakthrough device […]
FDA OKs trial for Micro Medical’s below-the-knee stent
Micro Medical Solutions said yesterday that it won a nod from the FDA to run a clinical trial of its MicroStent below-the-knee device for treating peripheral artery disease. The Wilmington, Mass.-based company’s MicroStent won CE Mark approval in the European Union in February 2017. A small feasibility study completed last fall met all primary endpoints […]
Micro Medical Solutions wins CE Mark for MicroStent BTK vascular stent
Microvascular interventional device dev Micro Medical Solutions said today it won CE Mark approval in the European Union for its MicroStent vascular stent designed for treating patients with peripheral artery disease. The Wilmington, Mass.-based company’s MicroStent is designed to reduce below-the-knee amputations for individuals with PAD resulting in critical limb ischemia. “The MicroStent is the […]